These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19217224)

  • 1. Clinical and echocardiographic diagnosis of patent ductus arteriosus in premature neonates.
    Chiruvolu A; Punjwani P; Ramaciotti C
    Early Hum Dev; 2009 Mar; 85(3):147-9. PubMed ID: 19217224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus.
    Occhipinti F; De Carolis MP; De Rosa G; Bersani I; Lacerenza S; Cota F; Rubortone SA; Romagnoli C
    J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1800-4. PubMed ID: 24397409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.
    Choi BM; Lee KH; Eun BL; Yoo KH; Hong YS; Son CS; Lee JW
    Pediatrics; 2005 Mar; 115(3):e255-61. PubMed ID: 15687418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care testing for B-type natriuretic peptide in premature neonates with patent ductus arteriosus.
    Kalra VK; DeBari VA; Zauk A; Kataria P; Myridakis D; Kiblawi F
    Ann Clin Lab Sci; 2011; 41(2):131-7. PubMed ID: 21844570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates.
    Flynn PA; da Graca RL; Auld PA; Nesin M; Kleinman CS
    J Pediatr; 2005 Jul; 147(1):38-42. PubMed ID: 16027692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.
    Hsu JH; Yang SN; Chen HL; Tseng HI; Dai ZK; Wu JR
    J Pediatr; 2010 Jul; 157(1):79-84. PubMed ID: 20227723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular biomarkers in the evaluation of patent ductus arteriosus in very preterm neonates: A cohort study.
    Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; Bech BH; Henriksen TB
    Early Hum Dev; 2020 Oct; 149():105142. PubMed ID: 32861196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-type and N-terminal pro-B-type natriuretic peptides are equally useful in assessing patent ductus arteriosus in very preterm infants.
    König K; Guy KJ; Drew SM; Barfield CP
    Acta Paediatr; 2015 Apr; 104(4):e139-42. PubMed ID: 25488470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent ductus arteriosus in preterm infants.
    Sasi A; Deorari A
    Indian Pediatr; 2011 Apr; 48(4):301-8. PubMed ID: 21532100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation.
    Slaughter JL; Cua CL; Notestine JL; Rivera BK; Marzec L; Hade EM; Maitre NL; Klebanoff MA; Ilgenfritz M; Le VT; Lewandowski DJ; Backes CH
    BMC Pediatr; 2019 Sep; 19(1):333. PubMed ID: 31519154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide to predict ductus intervention in infants <28 weeks.
    Czernik C; Lemmer J; Metze B; Koehne PS; Mueller C; Obladen M
    Pediatr Res; 2008 Sep; 64(3):286-90. PubMed ID: 18414139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.
    Sanjeev S; Pettersen M; Lua J; Thomas R; Shankaran S; L'Ecuyer T
    J Perinatol; 2005 Nov; 25(11):709-13. PubMed ID: 16222347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of the preterm patent ductus arteriosus: clinical signs, biomarkers, or ultrasound?
    Evans N
    Semin Perinatol; 2012 Apr; 36(2):114-22. PubMed ID: 22414882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.
    Ramakrishnan S; Heung YM; Round J; Morris TP; Collinson P; Williams AF
    Acta Paediatr; 2009 Aug; 98(8):1254-9. PubMed ID: 19432837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.
    Nuntnarumit P; Khositseth A; Thanomsingh P
    J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage.
    El-Khuffash A; Barry D; Walsh K; Davis PG; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov; 93(6):F407-12. PubMed ID: 18285375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial N-terminal pro-brain natriuretic peptide measurement as a predictor of significant patent ductus arteriosus in preterm infants beyond the first week of life.
    Letshwiti JB; Sirc J; O'Kelly R; Miletin J
    Eur J Pediatr; 2014 Nov; 173(11):1491-6. PubMed ID: 24898778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants.
    Alagarsamy S; Chhabra M; Gudavalli M; Nadroo AM; Sutija VG; Yugrakh D
    J Perinat Med; 2005; 33(2):161-4. PubMed ID: 15843268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of brain natriuretic propeptide in the diagnosis and management of patent ductus arteriosus].
    Montaner Ramón A; Galve Pradel Z; Fernández Espuelas C; Jiménez Montañés L; Samper Villagrasa MP; Rite Gracia S
    An Pediatr (Barc); 2017 Jun; 86(6):321-328. PubMed ID: 26936584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To evaluate the prevalence of symptomatic and non-symptomatic ductus arteriosus and accuracy of physical signs in diagnosing PDA in preterm infants using blinded comparison of clinical and echocardiographic findings during the first week of life: a prospective observational study from Iran.
    Pourarian S; Sharma D; Farahbakhsh N; Cheriki S; Bijanzadeh F
    J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1666-1670. PubMed ID: 27494450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.